世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

グリピジドの世界市場インサイト、2030年までの予測


Global Glipizide Market Insights, Forecast to 2030

グリピジド(CAS 29094-61-9)、C21H27N5O4S、式重量は445.54であり、その形状は白色結晶粉末である。 世界のグリピジド市場は、2024年の100万米ドルから2030年には100万米ドルに成長し、予測期間中の年間平均成... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年10月4日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

グリピジド(CAS 29094-61-9)、C21H27N5O4S、式重量は445.54であり、その形状は白色結晶粉末である。
世界のグリピジド市場は、2024年の100万米ドルから2030年には100万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は%と予測されている。
グリピジドは非インスリン依存性(II)型糖尿病の血糖降下薬で、食事療法だけでは良好な結果が得られない軽度から中等度の非インスリン依存性患者に使用される。

レポートの対象
本レポートでは、グリピジドの世界市場の概要、売上高、価格を紹介しています。2019年~2023年の過去の市場収益/売上データ、2024年の予測、2030年までのCAGR予測など、世界市場動向を分析。
本レポートでは、グリピジドの主要生産者を調査し、主要地域・国の売上高も掲載しています。グリピジドの今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点をハイライトしています。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、2019年から2024年までのデータで、主要メーカーのグリピジドの売上高、収益、市場シェア、業界ランキングに焦点を当てています。世界のグリピジド市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争環境を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2019年から2030年までのセグメントデータをタイプ別、用途別、売上高、収益、価格で分析しています。グリピジドの売上高、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。

市場区分
企業別
ファイザー
ユナイテッド・ラボラトリーズ
ディシャ・ファーマ
ピディ
ルカンファーマ
景峰志耀
ジャンプカン
CCPC
ヤシカファーマ
アポテックス
TEVA
タイプ別セグメント
グリピジド錠
グリピジド徐放錠
その他
用途別セグメント
病院薬局
小売薬局
オンライン薬局
地域別セグメント
米国およびカナダ
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

各章の概要
第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 世界、地域レベル、国レベルでのグリピジドの販売(消費)、収益各地域と主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。
第3章:グリピジドメーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章:各市場セグメントの売上高、収益、平均価格、発展の可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのを助けるために、タイプ別に様々な市場セグメントの分析を提供します。
第5章:読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。
第6章 北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。
第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:中国:タイプ別、用途別、セグメント別の売上高、収益。
第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。
第10章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第11章:主要メーカーのプロファイルを提供し、製品の説明や仕様、グリピジドの売上高、収益、価格、売上総利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。
第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介します。
第14章:レポートの要点と結論。


ページTOPに戻る


目次

1 Study Coverage
1.1 Glipizide Product Introduction
1.2 Market by Type
1.2.1 Global Glipizide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Glipizide Tablets
1.2.3 Glipizide Sustained Release Tablets
1.2.4 Others
1.3 Market by Application
1.3.1 Global Glipizide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glipizide Sales Estimates and Forecasts 2019-2030
2.2 Global Glipizide Revenue by Region
2.2.1 Global Glipizide Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Glipizide Revenue by Region (2019-2024)
2.2.3 Global Glipizide Revenue by Region (2025-2030)
2.2.4 Global Glipizide Revenue Market Share by Region (2019-2030)
2.3 Global Glipizide Sales Estimates and Forecasts 2019-2030
2.4 Global Glipizide Sales by Region
2.4.1 Global Glipizide Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Glipizide Sales by Region (2019-2024)
2.4.3 Global Glipizide Sales by Region (2025-2030)
2.4.4 Global Glipizide Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Glipizide Sales by Manufacturers
3.1.1 Global Glipizide Sales by Manufacturers (2019-2024)
3.1.2 Global Glipizide Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glipizide in 2023
3.2 Global Glipizide Revenue by Manufacturers
3.2.1 Global Glipizide Revenue by Manufacturers (2019-2024)
3.2.2 Global Glipizide Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Glipizide Revenue in 2023
3.3 Global Key Players of Glipizide, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Glipizide Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Glipizide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Glipizide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Glipizide, Product Offered and Application
3.8 Global Key Manufacturers of Glipizide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glipizide Sales by Type
4.1.1 Global Glipizide Historical Sales by Type (2019-2024)
4.1.2 Global Glipizide Forecasted Sales by Type (2025-2030)
4.1.3 Global Glipizide Sales Market Share by Type (2019-2030)
4.2 Global Glipizide Revenue by Type
4.2.1 Global Glipizide Historical Revenue by Type (2019-2024)
4.2.2 Global Glipizide Forecasted Revenue by Type (2025-2030)
4.2.3 Global Glipizide Revenue Market Share by Type (2019-2030)
4.3 Global Glipizide Price by Type
4.3.1 Global Glipizide Price by Type (2019-2024)
4.3.2 Global Glipizide Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Glipizide Sales by Application
5.1.1 Global Glipizide Historical Sales by Application (2019-2024)
5.1.2 Global Glipizide Forecasted Sales by Application (2025-2030)
5.1.3 Global Glipizide Sales Market Share by Application (2019-2030)
5.2 Global Glipizide Revenue by Application
5.2.1 Global Glipizide Historical Revenue by Application (2019-2024)
5.2.2 Global Glipizide Forecasted Revenue by Application (2025-2030)
5.2.3 Global Glipizide Revenue Market Share by Application (2019-2030)
5.3 Global Glipizide Price by Application
5.3.1 Global Glipizide Price by Application (2019-2024)
5.3.2 Global Glipizide Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Glipizide Market Size by Type
6.1.1 US & Canada Glipizide Sales by Type (2019-2030)
6.1.2 US & Canada Glipizide Revenue by Type (2019-2030)
6.2 US & Canada Glipizide Market Size by Application
6.2.1 US & Canada Glipizide Sales by Application (2019-2030)
6.2.2 US & Canada Glipizide Revenue by Application (2019-2030)
6.3 US & Canada Glipizide Market Size by Country
6.3.1 US & Canada Glipizide Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Glipizide Sales by Country (2019-2030)
6.3.3 US & Canada Glipizide Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Glipizide Market Size by Type
7.1.1 Europe Glipizide Sales by Type (2019-2030)
7.1.2 Europe Glipizide Revenue by Type (2019-2030)
7.2 Europe Glipizide Market Size by Application
7.2.1 Europe Glipizide Sales by Application (2019-2030)
7.2.2 Europe Glipizide Revenue by Application (2019-2030)
7.3 Europe Glipizide Market Size by Country
7.3.1 Europe Glipizide Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Glipizide Sales by Country (2019-2030)
7.3.3 Europe Glipizide Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Glipizide Market Size
8.1.1 China Glipizide Sales (2019-2030)
8.1.2 China Glipizide Revenue (2019-2030)
8.2 China Glipizide Market Size by Application
8.2.1 China Glipizide Sales by Application (2019-2030)
8.2.2 China Glipizide Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Glipizide Market Size by Type
9.1.1 Asia Glipizide Sales by Type (2019-2030)
9.1.2 Asia Glipizide Revenue by Type (2019-2030)
9.2 Asia Glipizide Market Size by Application
9.2.1 Asia Glipizide Sales by Application (2019-2030)
9.2.2 Asia Glipizide Revenue by Application (2019-2030)
9.3 Asia Glipizide Sales by Region
9.3.1 Asia Glipizide Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Glipizide Revenue by Region (2019-2030)
9.3.3 Asia Glipizide Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Glipizide Market Size by Type
10.1.1 Middle East, Africa and Latin America Glipizide Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Glipizide Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Glipizide Market Size by Application
10.2.1 Middle East, Africa and Latin America Glipizide Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Glipizide Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Glipizide Sales by Country
10.3.1 Middle East, Africa and Latin America Glipizide Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Glipizide Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Glipizide Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pfizer Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 United Laboratories
11.2.1 United Laboratories Company Information
11.2.2 United Laboratories Overview
11.2.3 United Laboratories Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 United Laboratories Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 United Laboratories Recent Developments
11.3 Disha Pharma
11.3.1 Disha Pharma Company Information
11.3.2 Disha Pharma Overview
11.3.3 Disha Pharma Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Disha Pharma Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Disha Pharma Recent Developments
11.4 PIDI
11.4.1 PIDI Company Information
11.4.2 PIDI Overview
11.4.3 PIDI Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 PIDI Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PIDI Recent Developments
11.5 Lukang Pharma
11.5.1 Lukang Pharma Company Information
11.5.2 Lukang Pharma Overview
11.5.3 Lukang Pharma Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Lukang Pharma Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lukang Pharma Recent Developments
11.6 Jingfeng Zhiyao
11.6.1 Jingfeng Zhiyao Company Information
11.6.2 Jingfeng Zhiyao Overview
11.6.3 Jingfeng Zhiyao Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Jingfeng Zhiyao Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jingfeng Zhiyao Recent Developments
11.7 Jumpcan
11.7.1 Jumpcan Company Information
11.7.2 Jumpcan Overview
11.7.3 Jumpcan Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Jumpcan Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jumpcan Recent Developments
11.8 CCPC
11.8.1 CCPC Company Information
11.8.2 CCPC Overview
11.8.3 CCPC Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 CCPC Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CCPC Recent Developments
11.9 Yashica Pharma
11.9.1 Yashica Pharma Company Information
11.9.2 Yashica Pharma Overview
11.9.3 Yashica Pharma Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Yashica Pharma Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yashica Pharma Recent Developments
11.10 Apotex
11.10.1 Apotex Company Information
11.10.2 Apotex Overview
11.10.3 Apotex Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Apotex Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Apotex Recent Developments
11.11 TEVA
11.11.1 TEVA Company Information
11.11.2 TEVA Overview
11.11.3 TEVA Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 TEVA Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 TEVA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glipizide Industry Chain Analysis
12.2 Glipizide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glipizide Production Mode & Process
12.4 Glipizide Sales and Marketing
12.4.1 Glipizide Sales Channels
12.4.2 Glipizide Distributors
12.5 Glipizide Customers
13 Market Dynamics
13.1 Glipizide Industry Trends
13.2 Glipizide Market Drivers
13.3 Glipizide Market Challenges
13.4 Glipizide Market Restraints
14 Key Findings in The Global Glipizide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Glipizide (CAS 29094-61-9), C21H27N5O4S, the formula weight is 445.54, and its form is white cyrstal powder.
The global Glipizide market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Glipizide is a hypoglycemic drug for non-insulin-dependent (II) type diabetes, which is used in patients with mild to moderate non-insulin-dependent patients who fail to achieve good results with diet control alone.

Report Covers:
This report presents an overview of global market for Glipizide, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Glipizide, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Glipizide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glipizide sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Glipizide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Glipizide sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation
By Company
Pfizer
United Laboratories
Disha Pharma
PIDI
Lukang Pharma
Jingfeng Zhiyao
Jumpcan
CCPC
Yashica Pharma
Apotex
TEVA
Segment by Type
Glipizide Tablets
Glipizide Sustained Release Tablets
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Glipizide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Glipizide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glipizide sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Glipizide Product Introduction
1.2 Market by Type
1.2.1 Global Glipizide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Glipizide Tablets
1.2.3 Glipizide Sustained Release Tablets
1.2.4 Others
1.3 Market by Application
1.3.1 Global Glipizide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Glipizide Sales Estimates and Forecasts 2019-2030
2.2 Global Glipizide Revenue by Region
2.2.1 Global Glipizide Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Glipizide Revenue by Region (2019-2024)
2.2.3 Global Glipizide Revenue by Region (2025-2030)
2.2.4 Global Glipizide Revenue Market Share by Region (2019-2030)
2.3 Global Glipizide Sales Estimates and Forecasts 2019-2030
2.4 Global Glipizide Sales by Region
2.4.1 Global Glipizide Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Glipizide Sales by Region (2019-2024)
2.4.3 Global Glipizide Sales by Region (2025-2030)
2.4.4 Global Glipizide Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Glipizide Sales by Manufacturers
3.1.1 Global Glipizide Sales by Manufacturers (2019-2024)
3.1.2 Global Glipizide Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glipizide in 2023
3.2 Global Glipizide Revenue by Manufacturers
3.2.1 Global Glipizide Revenue by Manufacturers (2019-2024)
3.2.2 Global Glipizide Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Glipizide Revenue in 2023
3.3 Global Key Players of Glipizide, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Glipizide Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Glipizide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Glipizide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Glipizide, Product Offered and Application
3.8 Global Key Manufacturers of Glipizide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glipizide Sales by Type
4.1.1 Global Glipizide Historical Sales by Type (2019-2024)
4.1.2 Global Glipizide Forecasted Sales by Type (2025-2030)
4.1.3 Global Glipizide Sales Market Share by Type (2019-2030)
4.2 Global Glipizide Revenue by Type
4.2.1 Global Glipizide Historical Revenue by Type (2019-2024)
4.2.2 Global Glipizide Forecasted Revenue by Type (2025-2030)
4.2.3 Global Glipizide Revenue Market Share by Type (2019-2030)
4.3 Global Glipizide Price by Type
4.3.1 Global Glipizide Price by Type (2019-2024)
4.3.2 Global Glipizide Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Glipizide Sales by Application
5.1.1 Global Glipizide Historical Sales by Application (2019-2024)
5.1.2 Global Glipizide Forecasted Sales by Application (2025-2030)
5.1.3 Global Glipizide Sales Market Share by Application (2019-2030)
5.2 Global Glipizide Revenue by Application
5.2.1 Global Glipizide Historical Revenue by Application (2019-2024)
5.2.2 Global Glipizide Forecasted Revenue by Application (2025-2030)
5.2.3 Global Glipizide Revenue Market Share by Application (2019-2030)
5.3 Global Glipizide Price by Application
5.3.1 Global Glipizide Price by Application (2019-2024)
5.3.2 Global Glipizide Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Glipizide Market Size by Type
6.1.1 US & Canada Glipizide Sales by Type (2019-2030)
6.1.2 US & Canada Glipizide Revenue by Type (2019-2030)
6.2 US & Canada Glipizide Market Size by Application
6.2.1 US & Canada Glipizide Sales by Application (2019-2030)
6.2.2 US & Canada Glipizide Revenue by Application (2019-2030)
6.3 US & Canada Glipizide Market Size by Country
6.3.1 US & Canada Glipizide Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Glipizide Sales by Country (2019-2030)
6.3.3 US & Canada Glipizide Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Glipizide Market Size by Type
7.1.1 Europe Glipizide Sales by Type (2019-2030)
7.1.2 Europe Glipizide Revenue by Type (2019-2030)
7.2 Europe Glipizide Market Size by Application
7.2.1 Europe Glipizide Sales by Application (2019-2030)
7.2.2 Europe Glipizide Revenue by Application (2019-2030)
7.3 Europe Glipizide Market Size by Country
7.3.1 Europe Glipizide Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Glipizide Sales by Country (2019-2030)
7.3.3 Europe Glipizide Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Glipizide Market Size
8.1.1 China Glipizide Sales (2019-2030)
8.1.2 China Glipizide Revenue (2019-2030)
8.2 China Glipizide Market Size by Application
8.2.1 China Glipizide Sales by Application (2019-2030)
8.2.2 China Glipizide Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Glipizide Market Size by Type
9.1.1 Asia Glipizide Sales by Type (2019-2030)
9.1.2 Asia Glipizide Revenue by Type (2019-2030)
9.2 Asia Glipizide Market Size by Application
9.2.1 Asia Glipizide Sales by Application (2019-2030)
9.2.2 Asia Glipizide Revenue by Application (2019-2030)
9.3 Asia Glipizide Sales by Region
9.3.1 Asia Glipizide Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Glipizide Revenue by Region (2019-2030)
9.3.3 Asia Glipizide Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Glipizide Market Size by Type
10.1.1 Middle East, Africa and Latin America Glipizide Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Glipizide Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Glipizide Market Size by Application
10.2.1 Middle East, Africa and Latin America Glipizide Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Glipizide Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Glipizide Sales by Country
10.3.1 Middle East, Africa and Latin America Glipizide Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Glipizide Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Glipizide Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pfizer Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 United Laboratories
11.2.1 United Laboratories Company Information
11.2.2 United Laboratories Overview
11.2.3 United Laboratories Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 United Laboratories Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 United Laboratories Recent Developments
11.3 Disha Pharma
11.3.1 Disha Pharma Company Information
11.3.2 Disha Pharma Overview
11.3.3 Disha Pharma Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Disha Pharma Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Disha Pharma Recent Developments
11.4 PIDI
11.4.1 PIDI Company Information
11.4.2 PIDI Overview
11.4.3 PIDI Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 PIDI Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PIDI Recent Developments
11.5 Lukang Pharma
11.5.1 Lukang Pharma Company Information
11.5.2 Lukang Pharma Overview
11.5.3 Lukang Pharma Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Lukang Pharma Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lukang Pharma Recent Developments
11.6 Jingfeng Zhiyao
11.6.1 Jingfeng Zhiyao Company Information
11.6.2 Jingfeng Zhiyao Overview
11.6.3 Jingfeng Zhiyao Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Jingfeng Zhiyao Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jingfeng Zhiyao Recent Developments
11.7 Jumpcan
11.7.1 Jumpcan Company Information
11.7.2 Jumpcan Overview
11.7.3 Jumpcan Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Jumpcan Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jumpcan Recent Developments
11.8 CCPC
11.8.1 CCPC Company Information
11.8.2 CCPC Overview
11.8.3 CCPC Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 CCPC Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CCPC Recent Developments
11.9 Yashica Pharma
11.9.1 Yashica Pharma Company Information
11.9.2 Yashica Pharma Overview
11.9.3 Yashica Pharma Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Yashica Pharma Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yashica Pharma Recent Developments
11.10 Apotex
11.10.1 Apotex Company Information
11.10.2 Apotex Overview
11.10.3 Apotex Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Apotex Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Apotex Recent Developments
11.11 TEVA
11.11.1 TEVA Company Information
11.11.2 TEVA Overview
11.11.3 TEVA Glipizide Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 TEVA Glipizide Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 TEVA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glipizide Industry Chain Analysis
12.2 Glipizide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glipizide Production Mode & Process
12.4 Glipizide Sales and Marketing
12.4.1 Glipizide Sales Channels
12.4.2 Glipizide Distributors
12.5 Glipizide Customers
13 Market Dynamics
13.1 Glipizide Industry Trends
13.2 Glipizide Market Drivers
13.3 Glipizide Market Challenges
13.4 Glipizide Market Restraints
14 Key Findings in The Global Glipizide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る